Devises / CYTK
CYTK: Cytokinetics Incorporated
35.33
USD
2.02
(5.41%)
Le taux de change de CYTK a changé de -5.41% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 35.22 et à un maximum de 37.73.
Suivez la dynamique Cytokinetics Incorporated. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CYTK Nouvelles
- Cytokinetics And The 'Provocative Conversation' That Could Rewrite Heart Disease
- Will Camzyos Strengthen BMY's Cardiovascular Portfolio?
- Cytokinetics appoints James M. Daly to board of directors and compliance committee
- Cytokinetics: Specialty Franchise With Aficamten And Ulacamten (NASDAQ:CYTK)
- Cytokinetics appoints James Daly to board of directors
- Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript
- Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
- Cytokinetics shares rise on strong Q2 results
- Cytokinetics Inc earnings beat by $0.30, revenue topped estimates
- Techne (TECH) Beats Q4 Earnings and Revenue Estimates
- Raymond James downgrades Cytokinetics stock rating to Market Perform
- Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains?
- Cytokinetics (CYTK) CEO Blum sells $190k in stock
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cytokinetics CEO Robert Blum sells $169,000 in stock
- Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
- Cytokinetics at Jefferies Conference: Aficamten’s Market Expansion
- Cytokinetics to Participate in the Jefferies Global Healthcare Conference
- Mizuho cuts Cytokinetics stock target to $84 from $103
- Stifel maintains Buy rating and $87 target on Cytokinetics stock
- Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY)
- Cytokinetics at RBC Conference: Strategic Insights on Drug Development
- Tesla’s 2025 Shuffle: Buy the Dip or Dodge the Bullet?
- Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
Range quotidien
35.22
37.73
Range Annuel
29.31
59.39
- Clôture Précédente
- 37.35
- Ouverture
- 37.13
- Bid
- 35.33
- Ask
- 35.63
- Plus Bas
- 35.22
- Plus Haut
- 37.73
- Volume
- 8.123 K
- Changement quotidien
- -5.41%
- Changement Mensuel
- -5.08%
- Changement à 6 Mois
- -22.54%
- Changement Annuel
- -37.72%
31 août, dimanche